|
| 产地 | 美国 |
| 品牌 | Abbiotec |
| 货号 | 251868 |
| 保存条件 | -20℃ |
| 用途 | 科研 |
| 应用范围 | E, IHC, WB |
| 抗原来源 | |
| CAS编号 | |
| 保质期 | 一年 |
| 抗体名 | KCa3.1 |
| 是否单克隆 | 否 |
| 克隆性 | |
| 靶点 | |
| 适应物种 | H M R |
| 形态 | Each vial contains 0.1 mg IgG in 0.1 ml (1 mg/ml) of PBS pH7.4, 0.5% BSA with 0.09% sodium azide and 0.005% thimerosal. |
| 宿主 | Rabbit |
| 标记物 | |
| 包装规格 | 0.1mg |
| 纯度 | % |
| 亚型 | IgG |
| 标识物 | |
| 浓度 | % |
| 免疫原 | KLH-conjugated synthetic peptide encompassing a sequence within the N-term region of human KCa3.1. |
| 是否进口 | 是 |
产品背景Description
Intermediate conductance calcium-activated potassium channel protein 4 (KCa3.1) forms a voltage-independent potassium channel that is activated by intracellular calcium. Activation of KCa3.1 is followed by membrane hyperpolarization which promotes calcium influx. The channel is blocked by clotrimazole and charybdotoxin but is insensitive to apamin.
别名Alternate Names
Intermediate conductance calcium-activated potassium channel protein 4; SKCa 4; SKCa4; SK4; KCa3.1; KCa4; IKCa1; IK1; Putative Gardos channel; KCNN4; IK1; IKCA1; KCA4; SK4
应用说明Application Notes
E: 1:500-1:1,000; WB: 1:100-1:500; IHC: 1:100-1:500
引用文献Product Citations
Song P. et al. 2017. J Cancer. PMID 28775776.
